Feng-Hua Fu Selected Research

Feng-Hua Fu Research Topics

Disease

4	Pain (Aches) 01/2021 - 09/2009
3	Inflammation (Inflammations) 01/2021 - 07/2009
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2020
2	Hemorrhage 01/2014 - 07/2010
2	Poisoning 05/2012 - 05/2003
2	Sepsis (Septicemia) 12/2009 - 07/2009
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2022
1	Constipation 11/2022
1	Stroke (Strokes) 06/2021
1	Hypertension (High Blood Pressure) 06/2021
1	Hypertrophy 06/2021
1	Cerebral Hemorrhage 01/2021
1	Neoplasms (Cancer) 12/2017
1	Insulin Resistance 03/2017
1	Hyperglycemia 03/2017
1	Mononeuropathies (Mononeuritis Multiplex) 01/2017
1	Cardiotoxicity 01/2012
1	Heart Injuries 01/2012
1	Lung Injury 10/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2011
1	Fibrosis (Cirrhosis) 03/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2009
1	Body Weight (Weight, Body) 11/2009
1	Brain Ischemia (Cerebral Ischemia) 08/2005
1	Thrombosis (Thrombus) 08/2005
1	Ischemia 08/2005
1	Cerebral Infarction 08/2005

Drug/Important Bio-Agent (IBA)

3	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021 - 09/2009
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
3	Calcitonin Gene-Related PeptideIBA 01/2021 - 09/2009
2	LipopolysaccharidesIBA 11/2022 - 07/2009
2	Therapeutic UsesIBA 06/2021 - 08/2005
2	calcitonin gene-related peptide (8-37)IBA 01/2021 - 09/2009
2	GalaninIBA 01/2017 - 01/2017
2	Type 2 Galanin ReceptorIBA 01/2017 - 01/2017
2	Methyl Parathion (Dalf)IBA 05/2012 - 10/2011
2	Rosmarinic AcidIBA 03/2010 - 12/2009
1	Loperamide (Imodium)FDA LinkGeneric 11/2022
1	salicylhydroxamic acid (SHAM)IBA 06/2021
1	allisartan isoproxilIBA 06/2021
1	AldosteroneIBA 06/2021
1	AngiotensinsIBA 06/2021
1	Malondialdehyde (Propanedial)IBA 06/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2021
1	Calcitonin Receptor-Like ProteinIBA 01/2021
1	EscinIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	PCC0208009IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	PolyaminesIBA 12/2017
1	hederageninIBA 12/2017
1	Cytotoxins (Cytolysins)IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 03/2017
1	PlasticsIBA 01/2017
1	ORALIT (ORS)IBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012
1	Protective AgentsIBA 01/2012
1	sodium aescinateIBA 10/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2011
1	3,4-dihydroxyphenyllactic acidIBA 01/2011
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2010
1	Indicators and Reagents (Reagents)IBA 03/2010
1	astilbinIBA 11/2009
1	Peptides (Polypeptides)IBA 09/2009
1	I-kappa B KinaseIBA 07/2009
1	NF-kappa B (NF-kB)IBA 07/2009
1	peoniflorinIBA 07/2009
1	Nimodipine (Modus)FDA LinkGeneric 08/2005
1	Adenosine Diphosphate (ADP)IBA 08/2005
1	Immunoglobulin Fab FragmentsIBA 05/2003

Therapy/Procedure

3	Ligation 01/2021 - 07/2009
2	Surgical Instruments (Clip) 06/2021 - 01/2014
2	Punctures 12/2009 - 07/2009
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2022
1	Therapeutics 01/2020
1	Analgesia 01/2020
1	Oral Administration 03/2017
1	Argon Plasma Coagulation 01/2014
1	Intravenous Administration 07/2010
1	Intraperitoneal Injections 07/2009
1	Sutures (Suture) 08/2005